Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michel Maillard is active.

Publication


Featured researches published by Michel Maillard.


Tetrahedron Letters | 1989

Synthesis of 3′-substituted-2′,3′-dideoxynucleoside analogs as potential anti-aids drugs

Michel Maillard; Abdesslem Faraj; François Frappier; Jean-Claude Florent; David S. Grierson; Claude Monneret

Abstract 3′-Amino-3′-deoxythymidine 9 was prepared in six steps and in 67% overall yield from thymidine. Five derivatives of 9 and compound 17 were tested for their anti-HIV activity.


European Journal of Medicinal Chemistry | 1992

Synthesis and evaluation of new 2′,3′-dideoxynucleoside analogs as potential anti-AIDS and anti-herpes drugs

A Faraj; Michel Maillard; Marc Lemaitre; S Letellier; F Frappier; Jc Florent; David S. Grierson; Claude Monneret; Aurelio Zerial

Abstract Based on the known structure-activity relationships for the active anti-HIV, a series of 3′-deoxy-3′- N -functionalized thymidine analogs has been synthesized from thymidine. Evaluation for inhibitory activity against human immunodeficiency virus (HIV) replication in CEM cells and against herpes simplex virus in MRC-5 cells is reported.


Bioorganic & Medicinal Chemistry Letters | 1992

Preparation and anti-HIV activity of N-3 amino substituted thymidine nucleoside analogs

Michel Maillard; Jean-Claude Florent; Marc Lemaitre; Francoise Begassat; Alain Bugnicourt; Chantal Ferrieux; Christine Rombi; Elizabeth Pacaud; Dominique Thierry; Aurelio Zerial; Claude Monneret; David S. Grierson

Abstract The N-3 amino derivatives 7–10 of ddT, AZT, 3′-FddT, and D4T were prepared by electrophilic amination of the parent compounds. Although compounds 7 , 9 , and 10 were essentially inactive, N-3 amino AZT 8 (RP67042) maintained activity and displayed lower toxicity and a longer plasmatic halflife compared to AZT.


Archive | 2002

N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives

Varghese John; Michel Maillard; Barbara Jagodzinska; James P. Beck; Andrea Gailunas; John Freskos; John Mickelson; Lakshman Samala; Jennifer Sealy; Ruth E. Tenbrink; Lawrence Fang


Journal of Medicinal Chemistry | 2007

Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human β-Secretase†

Michel Maillard; Roy K. Hom; Timothy E. Benson; Joseph B. Moon; Shumeye S. Mamo; Michael J. Bienkowski; Alfredo G. Tomasselli; D. Danielle Woods; D. Bryan Prince; Donna J. Paddock; Thomas L. Emmons; John A. Tucker; Michael S. Dappen; Louis Brogley; Eugene D. Thorsett; Nancy Jewett; and Sukanto Sinha; Varghese John


Archive | 2003

Acetyl 2-hydroxy-1, 3-diaminoalkanes

Varghese John; Michel Maillard; James P. Beck; Eric T. Baldwin; Robert Hughes; Shon R. Pulley; Ruth T. TenBrink


Journal of Medicinal Chemistry | 1998

Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N, N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels

Michel Maillard; Michael E. Perlman; Oved Amitay; Deborah Baxter; David J. Berlove; Sonia Connaughton; James B. Fischer; Jun Qing Guo; Lain-Yen Hu; Robert N. McBurney; Peter I. Nagy; Katragadda Subbarao; Elizabeth Yost; Lu Zhang; Graham John Durant


Archive | 2003

Methods of treating alzheimer's disease using aryl alkanoic acid amides

Varghese John; Michel Maillard


Journal of Medicinal Chemistry | 1997

Preparation and anti-HIV activity of N-3-substituted thymidine nucleoside analogs

David R. Adams; Caroline Perez; Michel Maillard; Jean-Claude Florent; Michel Evers; Yvette Henin; Simon Litvak; Laura Litvak; Claude Monneret; David S. Grierson


Archive | 2005

Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors

Varghese John; Michel Maillard; Lawrence Fang; John A. Tucker; Louis Brogley; Jose Aquino; Simeon Bowers; Gary D. Probst; Jay S. Tung

Collaboration


Dive into the Michel Maillard's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barbara Jagodzinska

Buck Institute for Research on Aging

View shared research outputs
Top Co-Authors

Avatar

Gary D. Probst

Millennium Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar

Jay S. Tung

Thomas Jefferson University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge